276 related articles for article (PubMed ID: 3470787)
1. Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin.
Shapiro R; Vallee BL
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2238-41. PubMed ID: 3470787
[TBL] [Abstract][Full Text] [Related]
2. Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor.
Lee FS; Shapiro R; Vallee BL
Biochemistry; 1989 Jan; 28(1):225-30. PubMed ID: 2706246
[TBL] [Abstract][Full Text] [Related]
3. Human angiogenin, an organogenic protein.
Riordan JF; Vallee BL
Br J Cancer; 1988 Jun; 57(6):587-90. PubMed ID: 2457389
[TBL] [Abstract][Full Text] [Related]
4. Interaction of human placental ribonuclease with placental ribonuclease inhibitor.
Shapiro R; Vallee BL
Biochemistry; 1991 Feb; 30(8):2246-55. PubMed ID: 1998683
[TBL] [Abstract][Full Text] [Related]
5. Isolation of bovine angiogenin using a placental ribonuclease inhibitor binding assay.
Bond MD; Vallee BL
Biochemistry; 1988 Aug; 27(17):6282-7. PubMed ID: 3064806
[TBL] [Abstract][Full Text] [Related]
6. Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of ribosomes.
St Clair DK; Rybak SM; Riordan JF; Vallee BL
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8330-4. PubMed ID: 3479795
[TBL] [Abstract][Full Text] [Related]
7. Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis.
Shapiro R; Vallee BL
Biochemistry; 1989 Sep; 28(18):7401-8. PubMed ID: 2479414
[TBL] [Abstract][Full Text] [Related]
8. Tryptophan fluorescence as a probe of placental ribonuclease inhibitor binding to angiogenin.
Lee FS; Auld DS; Vallee BL
Biochemistry; 1989 Jan; 28(1):219-24. PubMed ID: 2706245
[TBL] [Abstract][Full Text] [Related]
9. Characterization of ribonucleolytic activity of angiogenin towards tRNA.
Lee FS; Vallee BL
Biochem Biophys Res Commun; 1989 May; 161(1):121-6. PubMed ID: 2730651
[TBL] [Abstract][Full Text] [Related]
10. Expression of human placental ribonuclease inhibitor in Escherichia coli.
Lee FS; Vallee BL
Biochem Biophys Res Commun; 1989 Apr; 160(1):115-20. PubMed ID: 2653313
[TBL] [Abstract][Full Text] [Related]
11. Binding of placental ribonuclease inhibitor to the active site of angiogenin.
Lee FS; Vallee BL
Biochemistry; 1989 Apr; 28(8):3556-61. PubMed ID: 2742853
[TBL] [Abstract][Full Text] [Related]
12. Kinetic characterization of two active mutants of placental ribonuclease inhibitor that lack internal repeats.
Lee FS; Vallee BL
Biochemistry; 1990 Jul; 29(28):6633-8. PubMed ID: 2397204
[TBL] [Abstract][Full Text] [Related]
13. An in vitro binding assay for angiogenin using placental ribonuclease inhibitor.
Bond MD
Anal Biochem; 1988 Aug; 173(1):166-73. PubMed ID: 3189795
[TBL] [Abstract][Full Text] [Related]
14. Mutagenesis of aspartic acid-116 enhances the ribonucleolytic activity and angiogenic potency of angiogenin.
Harper JW; Vallee BL
Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7139-43. PubMed ID: 2459697
[TBL] [Abstract][Full Text] [Related]
15. Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of 40S ribosomes.
St Clair DK; Rybak SM; Riordan JF; Vallee BL
Biochemistry; 1988 Sep; 27(19):7263-8. PubMed ID: 3207674
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro studies of angiogenin--a potent angiogenic factor.
Badet J; Soncin F; N'Guyen T; Barritault D
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):721-4. PubMed ID: 1723310
[TBL] [Abstract][Full Text] [Related]
17. A covalent angiogenin/ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesis.
Harper JW; Vallee BL
Biochemistry; 1989 Feb; 28(4):1875-84. PubMed ID: 2719939
[TBL] [Abstract][Full Text] [Related]
18. C-terminal angiogenin peptides inhibit the biological and enzymatic activities of angiogenin.
Rybak SM; Auld DS; St Clair DK; Yao QZ; Fett JW
Biochem Biophys Res Commun; 1989 Jul; 162(1):535-43. PubMed ID: 2473749
[TBL] [Abstract][Full Text] [Related]
19. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains.
Newton DL; Xue Y; Olson KA; Fett JW; Rybak SM
Biochemistry; 1996 Jan; 35(2):545-53. PubMed ID: 8555226
[TBL] [Abstract][Full Text] [Related]
20. Dual site model for the organogenic activity of angiogenin.
Hallahan TW; Shapiro R; Vallee BL
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2222-6. PubMed ID: 2006161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
